Australian listed healthcare company Stirling Products (ASX:STI) has advised that following over six months of research and planning the company is establishing a US network marketing subsidiary to undertake its product launch in North America.
First products to be launched will be ImmunoXel, Cholonorm, Diabetin and Allergon.
The company believes the network marketing approach offers the best leverage for its unique botanical products.
And, provide a rapidly expanding customer base built on referrals without the need to provide for a multi-million
advertising budget, which would otherwise be required for a North American product launch.Peter Boonen said the company is conservatively targeting having a minimum of 2,500 sales consultants retained within the first six months of operations in North America.
Source: Proactive Investors
Dear Mr. Peter Boonen my name is Rusty and presently living in Thailand but I am a retired american living on social security. I believe at this point you have a winning product and utilizing network marketing is brilliant. You should have NO COMPETITION. I will gladly make an immediate move back to the states or wherever you wish to be part of the explosion of sales I think you will have. I have not much money living on social security however this opportunity MIGHT change my living standards if I can get involved from the beginning. Please forward to me where you would like me to help market your products and your aniticipated date of operations with your marketing plan to include the compensation plan for the networking. Please!!!!!!!!!!!! I am anxiously awaiting your information so as to make a plan of work expenses etc. Thank You…Rusty